NEW YORK (GenomeWeb) – Bio-Rad Laboratories has announced a partnership with Genetic Analysis, an Oslo, Norway-based clinical diagnostics firm focusing on the microbiome.

Under the terms of the agreement, Bio-Rad will make an equity investment in Genetic Analysis. In return, it will receive commercialization rights in certain undisclosed territories for Genetic Analysis' CE-marked GA-map technology to detect microbial imbalances, also known as gut dysbiosis, the firms said in a statement.

Financial and other details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Five researchers are to share this year's Albany Medical Center Prize for their work on the CRISPR/Cas9 gene-editing tool, the AP reports.

Stat News reports on how white supremacists cope with surprising genetic ancestry testing results.

In Genome Research this week: sex-biased gene expression evolution in malaria mosquitos, method to find ancient selective sweeps, and more.

Iceland has nearly eliminated Down syndrome from its population, CBS News reports.